SMTL ID : 3w33.1

EGFR kinase domain complexed with compound 19b

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x W19: 4-{[4-(1-benzothiophen-4-yloxy)-3-chlorophenyl]amino}-N-(2-hydroxyethyl)-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxamide(Non-covalent)

W19.1: 20 residues within 4Å: Chain A: L.26, G.27, V.34, A.51, K.53, C.83, R.84, L.85, L.96, T.98, Q.99, L.100, M.101, G.104, C.105, L.152, T.162, D.163, F.164, L.166 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.34, A:A.51, A:K.53, A:L.96, A:T.98, A:L.152, A:T.162, A:L.166 Hydrogen bonds: A:M.101, A:M.101 Water bridges: A:C.105 pi-Stacking: A:F.164 Halogen bonds: A:L.96

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: R.111, K.221 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.111, A:K.221

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kawakita, Y. et al., Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors. Bioorg.Med.Chem. (2013)

Release Date

2013-03-06

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence